Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current progress on nucleoside antibiotics.

K Isono1

  • 1Antibiotics Laboratory, RIKEN, Institute of Physical and Chemical Research, Saitama-ken, Japan.

Pharmacology & Therapeutics
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A putative blue-light receptor from Drosophila melanogaster.

Photochemistry and photobiology·1999
Same author

Selective inhibition of the bacterial peptidoglycan biosynthesis by the new types of liposidomycins.

The Journal of antibiotics·1999
Same author

Importance of positive peritoneal lavage cytology findings in the stage grouping of gastric cancer.

Surgery today·1999
Same author

Inhibition of peritoneal dissemination of murine colon carcinoma cells by administrating retrovirus harboring IL-2 gene.

Cancer gene therapy·1999
Same author

Role of donor passenger leukocytes on the induction of tolerance in rat liver transplantation.

Transplantation proceedings·1998
Same author

The metabolic pathway of visual pigment chromophore formation in Drosophila melanogaster--all-trans (3S)-3-hydroxyretinal is formed from all-trans retinal via (3R)-3-hydroxyretinal in the dark.

European journal of biochemistry·1998
Same journal

Harnessing multispecific antibodies for next-generation cancer treatments.

Pharmacology & therapeutics·2026
Same journal

Protein acetylation modification in tissue fibrosis: Opportunities and challenges.

Pharmacology & therapeutics·2026
Same journal

Nipocalimab and other FcRn blockers in neuromuscular disorders.

Pharmacology & therapeutics·2026
Same journal

C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy.

Pharmacology & therapeutics·2026
Same journal

The CircRNA/miRNA axis in breast cancer: From molecular mechanisms to clinical translation.

Pharmacology & therapeutics·2026
Same journal

Glymphatic-meningeal lymphatic dysfunction in epilepsy: novel mechanistic insights and therapeutic avenues.

Pharmacology & therapeutics·2026
See all related articles

This review details 36 novel nucleoside antibiotics and synthetic analogs, focusing on their biological activity and antiviral potential. It also covers new biosynthetic insights into established antibiotic classes.

Area of Science:

  • Medicinal Chemistry
  • Microbiology
  • Biochemistry

Background:

  • Nucleoside antibiotics represent a critical class of antimicrobial and antiviral agents.
  • Previous reviews have cataloged these compounds, with the last major update in 1988.
  • Continued research is essential for discovering new therapeutic agents.

Purpose of the Study:

  • To review the structure and biological activity of novel nucleoside antibiotics discovered since 1988.
  • To highlight synthetic analogs of known nucleoside antibiotics, particularly neplanocin and oxetanocin, for antiviral applications.
  • To summarize recent advancements in the biosynthesis of nikkomycins, blasticidin S, and griseolic acid.

Main Methods:

  • Literature review of scientific publications and patents.

Related Experiment Videos

  • Analysis of structural data and reported biological activities.
  • Synthesis and characterization of novel nucleoside analogs.

    • Main Results:

    • Description of 36 new nucleoside antibiotics with characterized structures and activities.
    • Presentation of synthetic neplanocin and oxetanocin analogs demonstrating significant antiviral effects.
    • Review of updated biosynthetic pathways for nikkomycins, blasticidin S, and griseolic acid.

    Conclusions:

    • The field of nucleoside antibiotics remains dynamic, with numerous new compounds and analogs emerging.
    • Synthetic modifications offer promising avenues for developing potent antiviral drugs.
    • Advances in understanding biosynthesis can inform the development of novel production strategies.